Simplex Trading, LLC Atossa Therapeutics, Inc. Transaction History

Simplex Trading, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$0.8 - $1.89 $44,471 - $105,063	55,589 New	55,589 $100,000
Q4 2022 Feb 02, 2023	BUY	$0.5 - $1.01 $50 - $101	100 Added 3.13%	3,300 $1,000
Q3 2022 Nov 04, 2022	SELL	$0.82 - $1.14 $1,558 - $2,166	-1,900 Reduced 37.25%	3,200 $2,000
Q1 2022 May 02, 2022	SELL	$1.11 - $1.74 $6,660 - $10,440	-6,000 Reduced 54.05%	5,100 $6,000
Q4 2021 Feb 23, 2022	SELL	$1.6 - $3.27 $127,878 - $261,351	-79,924 Reduced 87.81%	11,100 $17,000
Q3 2021 Oct 28, 2021	SELL	$2.89 - $6.4 $146,011 - $323,347	-50,523 Reduced 35.69%	91,024 $582,000
Q2 2021 Aug 12, 2021	BUY	$1.52 - $8.62 $215,151 - $1.22 Million	141,547 New	141,547 $894,000
Q1 2021 Apr 26, 2021	SELL	$0.92 - $4.33 $368 - $1,732	-400 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$0.85 - $2.43 $243 - $697	287 Added 253.98%	400 $0
Q3 2020 Oct 14, 2020	BUY	$1.98 - $4.35 $223 - $491	113 New	113 $0

26.5M

466K

91.8K

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $130M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.